$ATXI SEC Filings

Filed On	Filing
07 Aug 2026	FORM 10-Q
08 May 2026	FORM 10-Q
30 Mar 2026	FORM 10-K
23 Feb 2026	8-K: Entry into a Material Definitive Agreement; Other Events
17 Feb 2026	SCHEDULE 13G/A
06 Jan 2026	Form 4: Fortress Biotech, Inc., 10% owner Received 111,209 shares as a grant or award
06 Jan 2026	SCHEDULE 13D/A
31 Dec 2025	8-K: Submission of Matters to a Vote of Security Holders
16 Dec 2025	EFFECT
15 Dec 2025	RW
15 Dec 2025	POS AM
05 Dec 2025	Proxy statement: annual meeting on December 30, 2025 CEO pay $840K, down 31%
18 Nov 2025	8-K: Shareholder Director Nominations; Other Events
13 Nov 2025	FORM 10-Q
12 Nov 2025	8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation +1 more
14 Aug 2025	FORM 10-Q
18 Jul 2025	25-NSE
15 May 2025	FORM 10-Q
30 Apr 2025	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +1 more
02 Apr 2025	Form 4: Fortress Biotech, Inc., 10% owner Received 33,724 shares as a grant or award

Comments